TrialVascular health and risk management2015

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.

Harold E Bays et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.